Interstitial Lung Disease service
The ILD service cares for around 500 patients with a variety of lung diseases including idiopathic pulmonary fibrosis (IPF), familial pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis, pulmonary fibrosis related to auto-immune diseases (systemic sclerosis, rheumatoid arthritis, SLE, Sjögren’s syndrome) and pulmonary fibrosis related to medications, chemotherapy or radiation treatment. Patients referred to the ILD service will undergo investigations including a CT scan, lung function, exercise tests, echocardiogram, bronchoscopy and in some instances a lung biopsy to establish the diagnosis.
All cases are reviewed by the multidisciplinary team consisting of respiratory physicians, radiologists, pathologists, thoracic surgeons, specialist nurse and respiratory physiotherapist to establish an appropriate management plan.
In addition to medical treatments, patients may receive breathlessness management, pulmonary rehabilitation and assessment of their oxygen requirements. The ILD service benefits from working closely with the pulmonary hypertension and the lung transplant services at Papworth Hospital.
The ILD service is involved with clinical and basic science research into the mechanisms of pulmonary fibrosis and sarcoidosis.
The service is supported by an active Pulmonary Fibrosis Support Group.
Back to thoracic services
Latest News
17 May 2013
Meeting of the Board of Directors
15 May 2013
Papworth gains national recognition for TAVI
30 April 2013
New gene therapy could treat devastating heart failure